Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-002527
Filing Date
2024-01-04
Accepted
2024-01-04 17:01:57
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d681719d424b5.htm 424B5 275940
2 EX-FILING FEES d681719dexfilingfees.htm EX-FILING FEES 29858
3 GRAPHIC g681719g00a26.jpg GRAPHIC 63475
  Complete submission text file 0001193125-24-002527.txt   394726
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 424B5 | Act: 33 | File No.: 333-268665 | Film No.: 24513026
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)